Influence of moisture on the crystal forms of niclosamide obtained from acetone and ethyl acetate

AAPS PharmSciTech

Volumn 5, Issue 1, 2004, Pages

  Manek, Rahul V ^a   Kolling, William M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Channel type solvates; Hydrate formation; Isomorphic desolvates; Niclosamide; Polymorphism; Relative humidity

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; NICLOSAMIDE; ACETIC ACID DERIVATIVE; ANTICESTODAL AGENT;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; HUMIDITY; MOISTURE; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION; CHEMISTRY; X RAY DIFFRACTION;

ACETATES; ACETONE; ANTICESTODAL AGENTS; CRYSTALLIZATION; NICLOSAMIDE; X-RAY DIFFRACTION;

EID: 23144456486     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/bf02830582     Document Type: Article

References (23)

1. Haleblian J, McCrone W. Pharmaceutical applications of polymorphism. J Pharm Sci. 1969;58:911-929.
2. Berger A, Ramberger R. On the polymorphism of pharmaceuticals and other molecular crystals. I. Mikrochim Acta. 1979;11:259-271.
3. Berger A, Ramberger R. On the polymorphism of pharmaceuticals and other molecular crystals II. Mikrochim Acta. 1979;11:273-316.
4. Stahl HP. The problems of drug interactions with excipients. In: Braimar DD, ed. Towards Better Safety of Drugs and Pharmaceutical Products. Amsterdam, The Netherlands: Elsevier; 1980:265-280.
5. Cambridge Structural Database [computer program]. Version. 2.3.7. Cambridge, UK; 1996.
6. Byrn SR, Pfeiffer RR, Stowell JG. Solid State Chemistry of Drugs. West Lafayette: SSCI Inc; 1999.
7. Pfeiffer RR, Yang KS, Tucker MA. Crystal pseudopolymorphism of cephaloglycin and cephalexin. J Pharm Sci. 1970;59:1809-1812.
8. Stephenson GA, Groleau EG, Kleemann RL, Xu W, Rigsbee DR. Formation of isomorphic desolvates: creating a molecular vacuum. J Pharm Sci. 1998;87:536-542.
9. O'Neil MJ, Smith A, Heckelman PE, et al, eds. Merck Index. 13th ed. Whitehouse Station, NJ: Merck & Co; 2001.
10. van Tonder EC, de Villiers MM, Lotter AP, Caira MR, Liebenberg W. Correlation between hydrate formation and the physical instability of suspensions prepared with different niclosamide crystal forms. Pharm Ind. 1998;60:722-725.
11. Caira MR, van Tonder EC, de Villiers MM, Lotter AP. Diverse modes of solvent inclusion in crystalline pseudopolymorphs of the anthelmintic drug niclosamide. J Inclusion Phenom Mol Recognit Chem. 1998;31:1-16.
12. Kuhnert-Brandstatter M. Thermomicroscopy in the Analysis of Pharmaceuticals. New York, NY: Pergamon Press; 1971.
13. Byrn SR, Lin CT. The effect of crystal packing and defects on desolvation of hydrated crystals of caffeine and L-(-)-1,4-cyclohexadiene-1-alanine [letter]. J Am Chem Soc. 1976;98:4004-4005.
14. Lin CT, Byrn SR. Desolvation of solvated organic crystals. Mol Cryst Liq Cryst. 1979;50:99-104.
15. van Tonder EC. Preparation and Characterization of Niclosamide Crystal Modifications [dissertation]. Potchefstroom, South Africa: Potchefstroom University for CHE; 1996.
16. Morris KR. Structural aspects of hydrates and solvates. In: Brittain HG, ed. Polymorphism in Pharmaceutical Solids. New York, NY: Marcel Dekker; 1999:125-181.
17. Pauling L. The Nature of the Chemical Bond. New York, NY: Cornell University Press; 1960.
18. Scheiner S. Hydrogen Bonding: A Theoretical Perspective. New York, NY: Oxford University Press; 1997.
19. United States Pharmacopeial Convention. X-Ray Diffraction, General Test <941>. United States Pharmacopeia, 25th ed. Rockville, MD: United States Pharmacopeial Convention; 2002:2088-2089.
20. Kitaigorodskii AI. Molecular Crystals and Molecules. New York, NY: Academic Press; 1973.
21. Gavezzotti A, Filippini G. Polymorphic forms of organic crystals at room conditions: thermodynamics and structural implications. J Am Chem Soc. 1995;117:12299-12305.
22. Gavezzotti A. Calculations on packing energies, packing efficiencies and rotational freedom for molecular crystals. Nouv J Chim. 1982;6:444-450.
23. Bauer JF, Dziki W, Quick JE. Role of isomorphic desolvates in dissolution failures of an erythromycin tablet formulation. J Pharm Sci. 1999;88:1222-1227.